1. COVID-fighting llamas inspire nanobody treatments to tackle emerging variants — Jury awards former AZ sales manager $2.4M in whistleblower retaliation case -- Teva to settle Mississippi drug price case See more on our front page news
    Dismiss Notice
  2. Do you have general questions about dealing with sexual harassment or discrimination at work? Ask an attorney on this forum.
    Dismiss Notice

Lilly's Olumiant Found to Lower Pain In Late-Stage Rheumatoid Arthritis Trial

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Jun 3, 2021 at 11:32 AM.

  1. cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    20,681
    Likes Received:
    4
    via Eli Lilly And Co (NYSE: LLY) has reported posthoc analyses data from the Phase 3 RA-BEAM study that showed Olumiant 4mg (baricitinib) lowered pain and duration of morning joint stiffness in moderate to severe rheumatoid arthritis (RA) patients.

    article source